These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24301651)

  • 1. FLAP pharmacological blockade modulates metabolism of endogenous tau in vivo .
    Chu J; Lauretti E; Di Meco A; Praticò D
    Transl Psychiatry; 2013 Dec; 3(12):e333. PubMed ID: 24301651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer's disease mouse model.
    Chu J; Praticò D
    J Neuroinflammation; 2012 Jun; 9():127. PubMed ID: 22697885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-lipoxygenase activating protein reduction ameliorates cognitive deficit, synaptic dysfunction, and neuropathology in a mouse model of Alzheimer's disease.
    Giannopoulos PF; Chu J; Joshi YB; Sperow M; Li JG; Kirby LG; Praticò D
    Biol Psychiatry; 2013 Sep; 74(5):348-56. PubMed ID: 23683389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockout of 5-lipoxygenase prevents dexamethasone-induced tau pathology in 3xTg mice.
    Joshi YB; Chu J; Praticò D
    Aging Cell; 2013 Aug; 12(4):706-11. PubMed ID: 23634895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5.
    Chu J; Praticò D
    Neurobiol Aging; 2013 Jun; 34(6):1549-54. PubMed ID: 23332172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
    J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
    J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
    Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
    J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal correlation of the memory deficit with Alzheimer-like lesions induced by activation of glycogen synthase kinase-3.
    Wang Y; Zhang JX; Du XX; Zhao L; Tian Q; Zhu LQ; Wang SH; Wang JZ
    J Neurochem; 2008 Sep; 106(6):2364-74. PubMed ID: 18643871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress hormone leads to memory deficits and altered tau phosphorylation in a model of Alzheimer's disease.
    Joshi YB; Chu J; Praticò D
    J Alzheimers Dis; 2012; 31(1):167-76. PubMed ID: 22531419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 12-15-lipoxygenase is a modulator of Alzheimer's-related tau pathology in vivo.
    Giannopoulos PF; Joshi YB; Chu J; Praticò D
    Aging Cell; 2013 Dec; 12(6):1082-90. PubMed ID: 23862663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.
    Zhu C; Xu B; Sun X; Zhu Q; Sui Y
    Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of 5-lipoxygenase on Alzheimer's disease-related tau pathology: in vivo and in vitro evidence.
    Chu J; Li JG; Ceballos-Diaz C; Golde T; Praticò D
    Biol Psychiatry; 2013 Sep; 74(5):321-8. PubMed ID: 23352590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.
    Takashima A; Honda T; Yasutake K; Michel G; Murayama O; Murayama M; Ishiguro K; Yamaguchi H
    Neurosci Res; 1998 Aug; 31(4):317-23. PubMed ID: 9809590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles.
    Chu J; Li JG; Praticò D
    PLoS One; 2013; 8(8):e70991. PubMed ID: 23951061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models.
    Wang D; Fu Q; Zhou Y; Xu B; Shi Q; Igwe B; Matt L; Hell JW; Wisely EV; Oddo S; Xiang YK
    J Biol Chem; 2013 Apr; 288(15):10298-307. PubMed ID: 23430246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
    Dobarro M; Gerenu G; Ramírez MJ
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.